Autism Spectrum Disorder Trial, Recruiting NCT05786898 Sponsor: Centre Hospitalier St Anne Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05786898
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Autism Spectrum Disorder (ASD) according to standard diagnostic guidelines (DSM-5)
  • People who attend one of the outpatient clinics taking part in this research
  • People whose ASD diagnosis has been confirmed using a specific diagnostic interview (ADI), with at least one parent present, or through a structured observation assessment (ADOS)
  • People who score at least 7 on a standardised comprehension test (either the WISC-5 for children or the WAIS-4 for adults)
  • People whose neuropsychological assessment shows some difficulties with thinking or cognitive skills, as identified by a neuropsychologist
  • People who have a level of understanding and communication that allows them to follow on-screen instructions during the exercises
  • For children: those who are able to attend a mainstream (non-specialised) school
  • For people taking psychiatric medication: those whose medication dose has been stable for more than one month

Who may not be able to join:

  • People who have a previously diagnosed intellectual disability
  • People who had difficulty understanding questions or instructions during the diagnostic interview
  • People who have a confirmed neurological condition
  • People who have received electroconvulsive therapy (ECT) in the past 6 months
  • People who have a sensory impairment (such as vision or hearing difficulties) that has not been corrected
  • People who are currently enrolled in another research study that has an exclusion period that has not yet ended
  • People who are currently taking daytime anxiety-reducing medications (anxiolytics) or a specific type of medication called anticholinergic correctors
  • People who are pregnant or breastfeeding
  • People who have taken part in cognitive remediation therapy (brain training or thinking skills therapy) within the last two years
  • For adults only: people whose assessment results show uneven levels of development across different cognitive skills (confirm with trial site)
  • For children only: children who are not currently attending school

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Isabelle Amado, GHU Paris Saint-Anne

Phone: 01.45.65.76.78

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier St Anne
Registry
ClinicalTrials.gov
Start date
24 January 2023
Est. completion
24 August 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Compliance; Enrollment rate; Retention rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov